National Cancer Institute; Notice of Closed Meeting, 29297 [2017-13466]

Download as PDF asabaliauskas on DSKBBXCHB2PROD with NOTICES Federal Register / Vol. 82, No. 123 / Wednesday, June 28, 2017 / Notices foundational principles. Every 10 years, through the Healthy People initiative, HHS leverages scientific insights and lessons from the past decade along with new knowledge of current data, trends, and innovations to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has set and monitored national health objectives to meet a broad range of health needs, encouraged collaborations across sectors, guided individuals toward making informed health decisions, and measured the impact of our prevention and health promotion activities. Healthy People 2030 will reflect assessments of major risks to health and wellness, changing public health priorities, new knowledge in prevention, and emerging issues related to our nation’s health preparedness. DATES: In order for comments on the proposed vision, mission, overarching goals, and framework for Healthy People 2030 to be considered, written comments must be submitted via the Internet at www.HealthyPeople.gov by 5:00 p.m. Eastern Time on September 29, 2017. ADDRESSES: The proposed framework for Healthy People 2030 can be viewed and commented upon at https:// www.healthypeople.gov. FOR FURTHER INFORMATION CONTACT: Ayanna Johnson, Public Health Advisor, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Suite LL100, Rockville, MD 20852, HP2030@hhs.gov (email), or (240) 245–8281 (fax). SUPPLEMENTARY INFORMATION: Background: The Healthy People development process strives to maximize transparency, public input and stakeholder dialogue to ensure that Healthy People 2030 is relevant to diverse public health needs and seizes opportunities to achieve its goals. Since its inception, Healthy People has become a broad-based, public engagement initiative with thousands of citizens helping to shape it at every step along the way. Drawing on the expertise of a Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 and public input, Healthy People will be organized to establish a framework to address risk factors and determinants of health and the diseases and disorders that are affecting our communities. Public participation will shape Healthy VerDate Sep<11>2014 17:22 Jun 27, 2017 Jkt 241001 People 2030, its purpose, goals, organization, and action plans. HHS is soliciting written public comments on the development of Healthy People 2030 through online public comment. As a national initiative, Healthy People’s success depends on a coordinated commitment to improve the health of the nation. Individuals may subscribe to the listserv at: https://bit.ly/2g3tqdE for the latest information on Healthy People 2020 and Healthy People 2030. Authority: 42 U.S.C. 200u. Dated: June 1, 2017. Don Wright, Deputy Assistant Secretary for Health, Disease Prevention and Health Promotion. [FR Doc. 2017–13463 Filed 6–27–17; 8:45 am] 29297 (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: June 22, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–13466 Filed 6–27–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4150–32–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Director; Notice of Meeting National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the NIH Clinical Center Research Hospital Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The portion of the meeting devoted to the identification and evaluation of specific candidates for consideration for a leadership position in the Clinical Center will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B) and 552b(c)(6), Title 5 U.S.C., as amended. Premature disclosure of potential candidates and their qualifications, as well as the discussions by the committee, could significantly frustrate NIH’s ability to recruit these individuals and the consideration of personnel qualifications, performance, and the competence of individuals as candidates would constitute a clearly unwarranted invasion of personal privacy. National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Frederick National Laboratory Advisory Committee to the National Cancer Institute. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The discussion of research projects/programs could disclose unpublished and financial data, technical information, confidential trade secrets or commercial property, such as patentable material, and personal information concerning investigators/ individuals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Frederick National Laboratory Advisory Committee to the National Cancer Institute. Date: July 18, 2017. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review the existing research portfolio (both intramural and extramural) and newly initiated research projects being conducted at the Frederick National Laboratory for Cancer Research (FNLCR). Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room TE406, Rockville, MD 20850 (Virtual Meeting). Contact Person: Caron A. Lyman, Ph.D., Executive Secretary, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 7W–126, Bethesda, MD 20892, 240–276–6348, lymanc@mail.nih.gov. PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 Name of Committee: NIH Clinical Center Research Hospital Board. Date: July 14, 2017. Open: 9:00 a.m. to 3:15 p.m. Agenda: Clinical Protocol Prioritization; Patient Safety Tracking; AAHRP 5 Year Accreditation Process; Bioethics; Report on CC Focus Groups. Place: National Institutes of Health, Building 31, 6th Floor, Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892. Closed: 3:30 p.m. to 5:00 p.m. E:\FR\FM\28JNN1.SGM 28JNN1

Agencies

[Federal Register Volume 82, Number 123 (Wednesday, June 28, 2017)]
[Notices]
[Page 29297]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13466]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Frederick National Laboratory Advisory Committee to the National Cancer 
Institute.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The discussion of research projects/programs could 
disclose unpublished and financial data, technical information, 
confidential trade secrets or commercial property, such as patentable 
material, and personal information concerning investigators/
individuals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Frederick National Laboratory Advisory 
Committee to the National Cancer Institute.
    Date: July 18, 2017.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review the existing research portfolio (both 
intramural and extramural) and newly initiated research projects 
being conducted at the Frederick National Laboratory for Cancer 
Research (FNLCR).
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room TE406, Rockville, MD 20850 (Virtual Meeting).
    Contact Person: Caron A. Lyman, Ph.D., Executive Secretary, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center Drive, Room 7W-126, Bethesda, MD 20892, 240-276-6348, 
lymanc@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: June 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13466 Filed 6-27-17; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.